SHLD Stock Overview
Through its subsidiaries, develops, manufactures, and sells a range of diagnostic and therapeutic products and services to healthcare providers worldwide. More details
| Snowflake Score | |
|---|---|
| Valuation | 4/6 |
| Future Growth | 2/6 |
| Past Performance | 4/6 |
| Financial Health | 2/6 |
| Dividends | 2/6 |
Siemens Healthineers AG Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | €50.03 |
| 52 Week High | €57.46 |
| 52 Week Low | €47.46 |
| Beta | 0.73 |
| 11 Month Change | -4.34% |
| 3 Month Change | -3.17% |
| 1 Year Change | 3.05% |
| 33 Year Change | -24.51% |
| 5 Year Change | 12.48% |
| Change since IPO | 65.20% |
Recent News & Updates
Recent updates
Shareholder Returns
| SHLD | GB Medical Equipment | GB Market | |
|---|---|---|---|
| 7D | -3.7% | 7.7% | -0.4% |
| 1Y | 3.0% | -2.1% | 5.6% |
Return vs Industry: SHLD exceeded the UK Medical Equipment industry which returned -2.1% over the past year.
Return vs Market: SHLD underperformed the UK Market which returned 5.6% over the past year.
Price Volatility
| SHLD volatility | |
|---|---|
| SHLD Average Weekly Movement | 5.1% |
| Medical Equipment Industry Average Movement | 6.1% |
| Market Average Movement | 4.7% |
| 10% most volatile stocks in GB Market | 10.2% |
| 10% least volatile stocks in GB Market | 2.6% |
Stable Share Price: SHLD has not had significant price volatility in the past 3 months compared to the UK market.
Volatility Over Time: Insufficient data to determine SHLD's volatility change over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| n/a | 72,300 | Bernd Montag | www.siemens-healthineers.com |
Siemens Healthineers AG, through its subsidiaries, develops, manufactures, and sells a range of diagnostic and therapeutic products and services to healthcare providers worldwide. It operates through four segments: Imaging, Diagnostics, Varian, and Advanced Therapies. The Imaging segment provides magnetic resonance imaging, computed tomography, X-ray systems, molecular imaging, and ultrasound systems.
Siemens Healthineers AG Fundamentals Summary
| SHLD fundamental statistics | |
|---|---|
| Market cap | €55.99b |
| Earnings (TTM) | €1.94b |
| Revenue (TTM) | €22.36b |
28.8x
P/E Ratio2.5x
P/S RatioIs SHLD overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| SHLD income statement (TTM) | |
|---|---|
| Revenue | €22.36b |
| Cost of Revenue | €13.90b |
| Gross Profit | €8.47b |
| Other Expenses | €6.53b |
| Earnings | €1.94b |
Last Reported Earnings
Sep 30, 2024
Next Earnings Date
Nov 26, 2024
| Earnings per share (EPS) | 1.74 |
| Gross Margin | 37.87% |
| Net Profit Margin | 8.68% |
| Debt/Equity Ratio | 89.0% |
How did SHLD perform over the long term?
See historical performance and comparison